1 Market Overview

1.1 Product Overview and Scope of Anti-Infective Therapy

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Anti-Infective Therapy by Type

1.3.1 Overview: Global Anti-Infective Therapy Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Anti-Infective Therapy Consumption Value Market Share by Type in 2022

1.3.3 Penicillin

1.3.4 Sulphonamides

1.3.5 Aminoglycosides

1.3.6 Fluoroquinolones

1.3.7 Antifungals

1.3.8 Antiprotozoal

1.3.9 Others

1.4 Global Anti-Infective Therapy Market by Application

1.4.1 Overview: Global Anti-Infective Therapy Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Home User

1.4.3 Hospitals/Clinics

1.4.4 Ambulatory Surgery Centres

1.4.5 Others

1.5 Global Anti-Infective Therapy Market Size & Forecast

1.6 Global Anti-Infective Therapy Market Size and Forecast by Region

1.6.1 Global Anti-Infective Therapy Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Anti-Infective Therapy Market Size by Region, (2018-2029)

1.6.3 North America Anti-Infective Therapy Market Size and Prospect (2018-2029)

1.6.4 Europe Anti-Infective Therapy Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Anti-Infective Therapy Market Size and Prospect (2018-2029)

1.6.6 South America Anti-Infective Therapy Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Anti-Infective Therapy Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Abbott Laboratories Ltd.

2.1.1 Abbott Laboratories Ltd. Details

2.1.2 Abbott Laboratories Ltd. Major Business

2.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Product and Solutions

2.1.4 Abbott Laboratories Ltd. Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Abbott Laboratories Ltd. Recent Developments and Future Plans

2.2 Cipla Ltd.

2.2.1 Cipla Ltd. Details

2.2.2 Cipla Ltd. Major Business

2.2.3 Cipla Ltd. Anti-Infective Therapy Product and Solutions

2.2.4 Cipla Ltd. Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Cipla Ltd. Recent Developments and Future Plans

2.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))

2.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Details

2.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Major Business

2.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product and Solutions

2.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Developments and Future Plans

2.4 Glenmark Pharmaceuticals Limited

2.4.1 Glenmark Pharmaceuticals Limited Details

2.4.2 Glenmark Pharmaceuticals Limited Major Business

2.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product and Solutions

2.4.4 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 Glenmark Pharmaceuticals Limited Recent Developments and Future Plans

2.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)

2.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Details

2.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Major Business

2.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product and Solutions

2.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Developments and Future Plans

2.6 Lupin Limited

2.6.1 Lupin Limited Details

2.6.2 Lupin Limited Major Business

2.6.3 Lupin Limited Anti-Infective Therapy Product and Solutions

2.6.4 Lupin Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Lupin Limited Recent Developments and Future Plans

2.7 Panacea Biotec Limited

2.7.1 Panacea Biotec Limited Details

2.7.2 Panacea Biotec Limited Major Business

2.7.3 Panacea Biotec Limited Anti-Infective Therapy Product and Solutions

2.7.4 Panacea Biotec Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Panacea Biotec Limited Recent Developments and Future Plans

2.8 Novartis AG

2.8.1 Novartis AG Details

2.8.2 Novartis AG Major Business

2.8.3 Novartis AG Anti-Infective Therapy Product and Solutions

2.8.4 Novartis AG Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Novartis AG Recent Developments and Future Plans

2.9 Pfizer, Inc.

2.9.1 Pfizer, Inc. Details

2.9.2 Pfizer, Inc. Major Business

2.9.3 Pfizer, Inc. Anti-Infective Therapy Product and Solutions

2.9.4 Pfizer, Inc. Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Pfizer, Inc. Recent Developments and Future Plans

2.10 Ranbaxy Laboratories Limited

2.10.1 Ranbaxy Laboratories Limited Details

2.10.2 Ranbaxy Laboratories Limited Major Business

2.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Product and Solutions

2.10.4 Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Ranbaxy Laboratories Limited Recent Developments and Future Plans

2.11 Sun Pharmaceutical Industries Limited

2.11.1 Sun Pharmaceutical Industries Limited Details

2.11.2 Sun Pharmaceutical Industries Limited Major Business

2.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product and Solutions

2.11.4 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Sun Pharmaceutical Industries Limited Recent Developments and Future Plans

2.12 AstraZeneca plc

2.12.1 AstraZeneca plc Details

2.12.2 AstraZeneca plc Major Business

2.12.3 AstraZeneca plc Anti-Infective Therapy Product and Solutions

2.12.4 AstraZeneca plc Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 AstraZeneca plc Recent Developments and Future Plans

2.13 Johnson & Johnson

2.13.1 Johnson & Johnson Details

2.13.2 Johnson & Johnson Major Business

2.13.3 Johnson & Johnson Anti-Infective Therapy Product and Solutions

2.13.4 Johnson & Johnson Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 Johnson & Johnson Recent Developments and Future Plans

2.14 WOCKHARDT

2.14.1 WOCKHARDT Details

2.14.2 WOCKHARDT Major Business

2.14.3 WOCKHARDT Anti-Infective Therapy Product and Solutions

2.14.4 WOCKHARDT Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 WOCKHARDT Recent Developments and Future Plans

2.15 F. Hoffmann-La Roche Ltd

2.15.1 F. Hoffmann-La Roche Ltd Details

2.15.2 F. Hoffmann-La Roche Ltd Major Business

2.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product and Solutions

2.15.4 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

2.16 Sanofi

2.16.1 Sanofi Details

2.16.2 Sanofi Major Business

2.16.3 Sanofi Anti-Infective Therapy Product and Solutions

2.16.4 Sanofi Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.16.5 Sanofi Recent Developments and Future Plans

2.17 Merck

2.17.1 Merck Details

2.17.2 Merck Major Business

2.17.3 Merck Anti-Infective Therapy Product and Solutions

2.17.4 Merck Anti-Infective Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.17.5 Merck Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Anti-Infective Therapy Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Anti-Infective Therapy by Company Revenue

3.2.2 Top 3 Anti-Infective Therapy Players Market Share in 2022

3.2.3 Top 6 Anti-Infective Therapy Players Market Share in 2022

3.3 Anti-Infective Therapy Market: Overall Company Footprint Analysis

3.3.1 Anti-Infective Therapy Market: Region Footprint

3.3.2 Anti-Infective Therapy Market: Company Product Type Footprint

3.3.3 Anti-Infective Therapy Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Anti-Infective Therapy Consumption Value and Market Share by Type (2018-2023)

4.2 Global Anti-Infective Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Anti-Infective Therapy Consumption Value Market Share by Application (2018-2023)

5.2 Global Anti-Infective Therapy Market Forecast by Application (2024-2029)

6 North America

6.1 North America Anti-Infective Therapy Consumption Value by Type (2018-2029)

6.2 North America Anti-Infective Therapy Consumption Value by Application (2018-2029)

6.3 North America Anti-Infective Therapy Market Size by Country

6.3.1 North America Anti-Infective Therapy Consumption Value by Country (2018-2029)

6.3.2 United States Anti-Infective Therapy Market Size and Forecast (2018-2029)

6.3.3 Canada Anti-Infective Therapy Market Size and Forecast (2018-2029)

6.3.4 Mexico Anti-Infective Therapy Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Anti-Infective Therapy Consumption Value by Type (2018-2029)

7.2 Europe Anti-Infective Therapy Consumption Value by Application (2018-2029)

7.3 Europe Anti-Infective Therapy Market Size by Country

7.3.1 Europe Anti-Infective Therapy Consumption Value by Country (2018-2029)

7.3.2 Germany Anti-Infective Therapy Market Size and Forecast (2018-2029)

7.3.3 France Anti-Infective Therapy Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Anti-Infective Therapy Market Size and Forecast (2018-2029)

7.3.5 Russia Anti-Infective Therapy Market Size and Forecast (2018-2029)

7.3.6 Italy Anti-Infective Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Anti-Infective Therapy Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Anti-Infective Therapy Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Anti-Infective Therapy Market Size by Region

8.3.1 Asia-Pacific Anti-Infective Therapy Consumption Value by Region (2018-2029)

8.3.2 China Anti-Infective Therapy Market Size and Forecast (2018-2029)

8.3.3 Japan Anti-Infective Therapy Market Size and Forecast (2018-2029)

8.3.4 South Korea Anti-Infective Therapy Market Size and Forecast (2018-2029)

8.3.5 India Anti-Infective Therapy Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Anti-Infective Therapy Market Size and Forecast (2018-2029)

8.3.7 Australia Anti-Infective Therapy Market Size and Forecast (2018-2029)

9 South America

9.1 South America Anti-Infective Therapy Consumption Value by Type (2018-2029)

9.2 South America Anti-Infective Therapy Consumption Value by Application (2018-2029)

9.3 South America Anti-Infective Therapy Market Size by Country

9.3.1 South America Anti-Infective Therapy Consumption Value by Country (2018-2029)

9.3.2 Brazil Anti-Infective Therapy Market Size and Forecast (2018-2029)

9.3.3 Argentina Anti-Infective Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Anti-Infective Therapy Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Anti-Infective Therapy Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Anti-Infective Therapy Market Size by Country

10.3.1 Middle East & Africa Anti-Infective Therapy Consumption Value by Country (2018-2029)

10.3.2 Turkey Anti-Infective Therapy Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Anti-Infective Therapy Market Size and Forecast (2018-2029)

10.3.4 UAE Anti-Infective Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Anti-Infective Therapy Market Drivers

11.2 Anti-Infective Therapy Market Restraints

11.3 Anti-Infective Therapy Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Anti-Infective Therapy Industry Chain

12.2 Anti-Infective Therapy Upstream Analysis

12.3 Anti-Infective Therapy Midstream Analysis

12.4 Anti-Infective Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Anti-Infective Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Anti-Infective Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Anti-Infective Therapy Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Anti-Infective Therapy Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Abbott Laboratories Ltd. Company Information, Head Office, and Major Competitors

Table 6. Abbott Laboratories Ltd. Major Business

Table 7. Abbott Laboratories Ltd. Anti-Infective Therapy Product and Solutions

Table 8. Abbott Laboratories Ltd. Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Abbott Laboratories Ltd. Recent Developments and Future Plans

Table 10. Cipla Ltd. Company Information, Head Office, and Major Competitors

Table 11. Cipla Ltd. Major Business

Table 12. Cipla Ltd. Anti-Infective Therapy Product and Solutions

Table 13. Cipla Ltd. Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. Cipla Ltd. Recent Developments and Future Plans

Table 15. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Information, Head Office, and Major Competitors

Table 16. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Major Business

Table 17. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product and Solutions

Table 18. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Developments and Future Plans

Table 20. Glenmark Pharmaceuticals Limited Company Information, Head Office, and Major Competitors

Table 21. Glenmark Pharmaceuticals Limited Major Business

Table 22. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product and Solutions

Table 23. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. Glenmark Pharmaceuticals Limited Recent Developments and Future Plans

Table 25. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Information, Head Office, and Major Competitors

Table 26. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Major Business

Table 27. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product and Solutions

Table 28. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Developments and Future Plans

Table 30. Lupin Limited Company Information, Head Office, and Major Competitors

Table 31. Lupin Limited Major Business

Table 32. Lupin Limited Anti-Infective Therapy Product and Solutions

Table 33. Lupin Limited Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. Lupin Limited Recent Developments and Future Plans

Table 35. Panacea Biotec Limited Company Information, Head Office, and Major Competitors

Table 36. Panacea Biotec Limited Major Business

Table 37. Panacea Biotec Limited Anti-Infective Therapy Product and Solutions

Table 38. Panacea Biotec Limited Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Panacea Biotec Limited Recent Developments and Future Plans

Table 40. Novartis AG Company Information, Head Office, and Major Competitors

Table 41. Novartis AG Major Business

Table 42. Novartis AG Anti-Infective Therapy Product and Solutions

Table 43. Novartis AG Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. Novartis AG Recent Developments and Future Plans

Table 45. Pfizer, Inc. Company Information, Head Office, and Major Competitors

Table 46. Pfizer, Inc. Major Business

Table 47. Pfizer, Inc. Anti-Infective Therapy Product and Solutions

Table 48. Pfizer, Inc. Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. Pfizer, Inc. Recent Developments and Future Plans

Table 50. Ranbaxy Laboratories Limited Company Information, Head Office, and Major Competitors

Table 51. Ranbaxy Laboratories Limited Major Business

Table 52. Ranbaxy Laboratories Limited Anti-Infective Therapy Product and Solutions

Table 53. Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Ranbaxy Laboratories Limited Recent Developments and Future Plans

Table 55. Sun Pharmaceutical Industries Limited Company Information, Head Office, and Major Competitors

Table 56. Sun Pharmaceutical Industries Limited Major Business

Table 57. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product and Solutions

Table 58. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Sun Pharmaceutical Industries Limited Recent Developments and Future Plans

Table 60. AstraZeneca plc Company Information, Head Office, and Major Competitors

Table 61. AstraZeneca plc Major Business

Table 62. AstraZeneca plc Anti-Infective Therapy Product and Solutions

Table 63. AstraZeneca plc Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. AstraZeneca plc Recent Developments and Future Plans

Table 65. Johnson & Johnson Company Information, Head Office, and Major Competitors

Table 66. Johnson & Johnson Major Business

Table 67. Johnson & Johnson Anti-Infective Therapy Product and Solutions

Table 68. Johnson & Johnson Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. Johnson & Johnson Recent Developments and Future Plans

Table 70. WOCKHARDT Company Information, Head Office, and Major Competitors

Table 71. WOCKHARDT Major Business

Table 72. WOCKHARDT Anti-Infective Therapy Product and Solutions

Table 73. WOCKHARDT Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 74. WOCKHARDT Recent Developments and Future Plans

Table 75. F. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors

Table 76. F. Hoffmann-La Roche Ltd Major Business

Table 77. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product and Solutions

Table 78. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 79. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

Table 80. Sanofi Company Information, Head Office, and Major Competitors

Table 81. Sanofi Major Business

Table 82. Sanofi Anti-Infective Therapy Product and Solutions

Table 83. Sanofi Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 84. Sanofi Recent Developments and Future Plans

Table 85. Merck Company Information, Head Office, and Major Competitors

Table 86. Merck Major Business

Table 87. Merck Anti-Infective Therapy Product and Solutions

Table 88. Merck Anti-Infective Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 89. Merck Recent Developments and Future Plans

Table 90. Global Anti-Infective Therapy Revenue (USD Million) by Players (2018-2023)

Table 91. Global Anti-Infective Therapy Revenue Share by Players (2018-2023)

Table 92. Breakdown of Anti-Infective Therapy by Company Type (Tier 1, Tier 2, and Tier 3)

Table 93. Market Position of Players in Anti-Infective Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 94. Head Office of Key Anti-Infective Therapy Players

Table 95. Anti-Infective Therapy Market: Company Product Type Footprint

Table 96. Anti-Infective Therapy Market: Company Product Application Footprint

Table 97. Anti-Infective Therapy New Market Entrants and Barriers to Market Entry

Table 98. Anti-Infective Therapy Mergers, Acquisition, Agreements, and Collaborations

Table 99. Global Anti-Infective Therapy Consumption Value (USD Million) by Type (2018-2023)

Table 100. Global Anti-Infective Therapy Consumption Value Share by Type (2018-2023)

Table 101. Global Anti-Infective Therapy Consumption Value Forecast by Type (2024-2029)

Table 102. Global Anti-Infective Therapy Consumption Value by Application (2018-2023)

Table 103. Global Anti-Infective Therapy Consumption Value Forecast by Application (2024-2029)

Table 104. North America Anti-Infective Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 105. North America Anti-Infective Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 106. North America Anti-Infective Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 107. North America Anti-Infective Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 108. North America Anti-Infective Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 109. North America Anti-Infective Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 110. Europe Anti-Infective Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 111. Europe Anti-Infective Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 112. Europe Anti-Infective Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 113. Europe Anti-Infective Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 114. Europe Anti-Infective Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 115. Europe Anti-Infective Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 116. Asia-Pacific Anti-Infective Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 117. Asia-Pacific Anti-Infective Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 118. Asia-Pacific Anti-Infective Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 119. Asia-Pacific Anti-Infective Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 120. Asia-Pacific Anti-Infective Therapy Consumption Value by Region (2018-2023) & (USD Million)

Table 121. Asia-Pacific Anti-Infective Therapy Consumption Value by Region (2024-2029) & (USD Million)

Table 122. South America Anti-Infective Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 123. South America Anti-Infective Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 124. South America Anti-Infective Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 125. South America Anti-Infective Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 126. South America Anti-Infective Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 127. South America Anti-Infective Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 128. Middle East & Africa Anti-Infective Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 129. Middle East & Africa Anti-Infective Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 130. Middle East & Africa Anti-Infective Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 131. Middle East & Africa Anti-Infective Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 132. Middle East & Africa Anti-Infective Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 133. Middle East & Africa Anti-Infective Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 134. Anti-Infective Therapy Raw Material

Table 135. Key Suppliers of Anti-Infective Therapy Raw Materials

List of Figures

Figure 1. Anti-Infective Therapy Picture

Figure 2. Global Anti-Infective Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Anti-Infective Therapy Consumption Value Market Share by Type in 2022

Figure 4. Penicillin

Figure 5. Sulphonamides

Figure 6. Aminoglycosides

Figure 7. Fluoroquinolones

Figure 8. Antifungals

Figure 9. Antiprotozoal

Figure 10. Others

Figure 11. Global Anti-Infective Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 12. Anti-Infective Therapy Consumption Value Market Share by Application in 2022

Figure 13. Home User Picture

Figure 14. Hospitals/Clinics Picture

Figure 15. Ambulatory Surgery Centres Picture

Figure 16. Others Picture

Figure 17. Global Anti-Infective Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 18. Global Anti-Infective Therapy Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 19. Global Market Anti-Infective Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 20. Global Anti-Infective Therapy Consumption Value Market Share by Region (2018-2029)

Figure 21. Global Anti-Infective Therapy Consumption Value Market Share by Region in 2022

Figure 22. North America Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 23. Europe Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 24. Asia-Pacific Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 25. South America Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 26. Middle East and Africa Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 27. Global Anti-Infective Therapy Revenue Share by Players in 2022

Figure 28. Anti-Infective Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 29. Global Top 3 Players Anti-Infective Therapy Market Share in 2022

Figure 30. Global Top 6 Players Anti-Infective Therapy Market Share in 2022

Figure 31. Global Anti-Infective Therapy Consumption Value Share by Type (2018-2023)

Figure 32. Global Anti-Infective Therapy Market Share Forecast by Type (2024-2029)

Figure 33. Global Anti-Infective Therapy Consumption Value Share by Application (2018-2023)

Figure 34. Global Anti-Infective Therapy Market Share Forecast by Application (2024-2029)

Figure 35. North America Anti-Infective Therapy Consumption Value Market Share by Type (2018-2029)

Figure 36. North America Anti-Infective Therapy Consumption Value Market Share by Application (2018-2029)

Figure 37. North America Anti-Infective Therapy Consumption Value Market Share by Country (2018-2029)

Figure 38. United States Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 39. Canada Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 40. Mexico Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 41. Europe Anti-Infective Therapy Consumption Value Market Share by Type (2018-2029)

Figure 42. Europe Anti-Infective Therapy Consumption Value Market Share by Application (2018-2029)

Figure 43. Europe Anti-Infective Therapy Consumption Value Market Share by Country (2018-2029)

Figure 44. Germany Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 45. France Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 46. United Kingdom Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 47. Russia Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 48. Italy Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 49. Asia-Pacific Anti-Infective Therapy Consumption Value Market Share by Type (2018-2029)

Figure 50. Asia-Pacific Anti-Infective Therapy Consumption Value Market Share by Application (2018-2029)

Figure 51. Asia-Pacific Anti-Infective Therapy Consumption Value Market Share by Region (2018-2029)

Figure 52. China Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 53. Japan Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 54. South Korea Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 55. India Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 56. Southeast Asia Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 57. Australia Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 58. South America Anti-Infective Therapy Consumption Value Market Share by Type (2018-2029)

Figure 59. South America Anti-Infective Therapy Consumption Value Market Share by Application (2018-2029)

Figure 60. South America Anti-Infective Therapy Consumption Value Market Share by Country (2018-2029)

Figure 61. Brazil Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 62. Argentina Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 63. Middle East and Africa Anti-Infective Therapy Consumption Value Market Share by Type (2018-2029)

Figure 64. Middle East and Africa Anti-Infective Therapy Consumption Value Market Share by Application (2018-2029)

Figure 65. Middle East and Africa Anti-Infective Therapy Consumption Value Market Share by Country (2018-2029)

Figure 66. Turkey Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 67. Saudi Arabia Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 68. UAE Anti-Infective Therapy Consumption Value (2018-2029) & (USD Million)

Figure 69. Anti-Infective Therapy Market Drivers

Figure 70. Anti-Infective Therapy Market Restraints

Figure 71. Anti-Infective Therapy Market Trends

Figure 72. Porters Five Forces Analysis

Figure 73. Manufacturing Cost Structure Analysis of Anti-Infective Therapy in 2022

Figure 74. Manufacturing Process Analysis of Anti-Infective Therapy

Figure 75. Anti-Infective Therapy Industrial Chain

Figure 76. Methodology

Figure 77. Research Process and Data Source